Skip to content
NASDAQ · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

HWH International Inc. ESYN

4 fiscal years on record · USD · FY2025 reported · SEC filings only
$866,926
▼ 30.8% YoY
$-2.6M
$-1.8M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 866,926.00
Revenue, FY2025 · full 4-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.9 · Net income -2.6
0.5M1.0M-1.0M-2.0M
20222025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−307 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -301.1% · Net -306.6%
-100%-200%-300%
202220232025
ROE

Not applicable: equity was zero or negative in this period, so return on equity has no meaning.

Three returns, three denominators.
Return on capital employedNot available: we don't have a clean operating profit figure for this period.

Each USD of equity lost 98 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -1.8
-1M-2M
202220232025
Net buybacks $M Dividends $M
FY2024 · Dividends · · Net buybacks 17.5
25.0M50.0M
20232024

Total assetsUSD 4.6M
EquityUSD 2.6M
CashUSD 2.1M
Current ratio2.32×

Equity funds 57% of total assets.

The 4-year record

4 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
ESYN, 4-year financial record
Metric 2025202420232022
Revenue $B0.00.00.0◌
Operating income $B−0.0−0.0−0.00.0
EBITDA $B−0.0−0.0−0.0◌
Income tax $B0.0◌0.00.0
Net income $B−0.0−0.0−0.00.0
Free cash flow $B−0.0−0.0−0.0◌
EPS, diluted $−0.40−0.76◌◌
Dividend / sh $◌◌◌◌
Payout % — not applicable: no dividend————
ROE %−97.7———
Shares out B0.010.010.00◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 20 reconciliationsAUDITED

Reconciled in 4 of the 4 fiscal years we could check. 28 checks were skipped: the balance sheet is not tagged before 2021. 17 checks were skipped: the share count is not tagged before 2024. 16 checks were skipped: revenue is not tagged before 2023.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityWholesale-Drugs, Proprietaries & Druggists' Sundries
Listed onNASDAQ
Incorporated inNevada
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2021

Share this section

Download image